A Closer Look at Lecanemab, Donanemab and Amyloid

Leqembi Vs Donanemab: Cure for Alzheimer's?

Professor Chris Rowe talks about promising new Alzheimer's drug Lecanemab

#015: Leqembi vs Donanemab - Cure for Alzheimer's?

New Alzheimer's drug, donanemab, to be approved by FDA end of this year

Groundbreaking Alzheimer’s drug offers new hope. #dementia #Alzheimer's#donanemab

Landmark study shows best signs yet Alzheimer's can be slowed | ABC News

Joanna Sun, Adapting the Australian Environmental Assessment Tool – High Care (EAT-HC) Dementia

Donanemab: A 'Turning Point' in Alzheimer's Clinical Trials with Promising Results

Lecanemab path to approval

The Hidden Danger of Alzheimer's Drugs

New drug "ray of hope" for Alzheimer’s patients

Hope and anxiety surround new Alzheimer’s drug lecanemab

Phase III AHEAD 3-45 trial of lecanemab for preclinical Alzheimer’s disease

Breakthrough in Alzheimer's Disease Treatment

Reshaping the Fight Against Alzheimer's: The Donanemab Revolution

How soon could lecanemab be prescribed to treat Alzheimer's?

New Alzheimer's drug is first 'to target the root cause'

ISTAART Relay Podcast - Immunity and Neurodegeneration PIA

ISTAART Relay Podcast - Frontotemporal Dementia PIA